Structure Therapeutics Incorporation

GPCR

Equity

ISIN null / Valor 124807608

NASDAQ (2025-12-24)

USD 69.69-2.24%

Structure Therapeutics Incorporation
UMushroom community rating:

3.44 8 votes No rating yet

NegativeNeutralPositive

About company

Structure Therapeutics Incorporation leverages advanced technologies in molecular visualization, computational chemistry, and data integration to develop innovative medicines. The company focuses on creating oral small molecule drugs that aim to achieve the efficacy and specificity typically associated with biologic and peptide drugs, while addressing the limitations inherent to these traditional therapies. By integrating cutting-edge scientific techniques, Structure Therapeutics seeks to provide differentiated therapeutic solutions that enhance patient outcomes.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

147%1Y

%3Y

%5Y

Performance

72.1%1Y

84.7%3Y

84.7%5Y

Volatility

4229 M

Market cap (USD)

745,372

Daily traded volume (Shares)

28.72 / 26.04

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.44

8 votes

Performance:

2.94

Innovation:

4.18

Society:

3.94

Nature:

3.59

Bastien Romanens

Switzerland, 02 Nov 2025

Virgil Zhu

United Kingdom, 27 Oct 2025

really depends on the news about clinical trials

****** Panggabean

United Kingdom, 26 Oct 2025

Strong innovation and a solid cash position, but the stock has been under pressure as R&D costs rise and profitability remains distant. The company’s GLP-1 pipeline offers promise, yet market sentiment reflects uncertainty about near-term returns.

EQUITIES OF THE SAME SECTOR

Fulton Financial Corp

Fulton Financial Corp Valor: 932114

Annual Return

-50%0%+50%

Risk level

110

0.25%USD 20.19

Industrivaerden AB

Industrivaerden AB Valor: 613221

Annual Return

-50%0%+50%

Risk level

110

0.19%SEK 411.60

Private Equity Holding Ltd

Private Equity Holding Ltd Valor: 608992

Annual Return

-50%0%+50%

Risk level

110

2.44%CHF 63.00

Alliance Resource Partners LP

Alliance Resource Partners LP Valor: 884116

Annual Return

-50%0%+50%

Risk level

110

0.72%USD 23.69

Zillow Group Inc

Zillow Group Inc Valor: 27201263

Annual Return

-50%0%+50%

Risk level

110

1.00%USD 68.85

Atrium Ljungberg

Atrium Ljungberg Valor: 267513

Annual Return

-50%0%+50%

Risk level

110

0.59%SEK 32.57

Columbia Banking System Inc

Columbia Banking System Inc Valor: 768354

Annual Return

-50%0%+50%

Risk level

110

0.03%USD 28.62

Catena AB

Catena AB Valor: 2522606

Annual Return

-50%0%+50%

Risk level

110

0.87%SEK 438.40

Columbia Financial Inc

Columbia Financial Inc Valor: 41461430

Annual Return

-50%0%+50%

Risk level

110

0.19%USD 16.17

Banner Corp

Banner Corp Valor: 12971823

Annual Return

-50%0%+50%

Risk level

110

0.02%USD 65.25

Logos provided by Clearbit

Structure Therapeutics Incorporation

GPCR

ISIN null / Valor 124807608

Structure Therapeutics Incorporation UMushroom community rating:

Bastien Romanens

Virgil Zhu

****** Panggabean

Structure Therapeutics Incorporation
UMushroom community rating: